DAC
Wellcome Trust Sanger Institute
Dac ID | Contact Person | Access Information | |
---|---|---|---|
EGAC00000000002 | Data Sharing | datasharing [at] sanger [dot] ac [dot] uk | No additional information is available |
This DAC controls 22 datasets:
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00000000017 | Cord blood control samples from Gambia | unknown | 0 |
EGAD00000000018 | Severe malaria cases from Gambia | unknown | 0 |
EGAD00000000019 | 840 families where both parents have been genotyped together with the child with severe malaria | unknown | 1 |
EGAD00000000020 | 685 families where both parents have been genotyped together with the child with severe malaria | unknown | 0 |
EGAD00010000570 | Imputation-based meta-analysis of severe malaria in Kenya. | 3343 | |
EGAD00010000572 | Imputation-based meta-analysis of severe malaria in Gambia. | unknown | 2870 |
EGAD00010000902 | Genome-wide study of resistance to severe malaria in eleven worldwide populations:Gambia | Illumina Omni 2.5M | 5594 |
EGAD00010000903 | Genome-wide study of resistance to severe malaria in eleven worldwide populations:Malawi | Illumina Omni 2.5M | 3088 |
EGAD00010000904 | Genome-wide study of resistance to severe malaria in eleven worldwide populations:Kenya | Illumina Omni 2.5M | 3865 |
EGAD00010001081 | Summary statistics for Malaria Genomic Epidemiology Network, "A novel locus of resistance to severe malaria in a region of ancient balancing selection", Nature (2015) | Illumina Omni 2.5M | 1 |
EGAD00010001733 | EGAS00001001311: Genome-wide study of resistance to severe malaria in eleven worldwide populations:Vietnam | Illumina Omni 2.5M | 1728 |
EGAD00010001734 | EGAS00001001311: Genome-wide study of resistance to severe malaria in eleven worldwide populations:Ghana | Illumina Omni 2.5M | 782 |
EGAD00010001735 | EGAS00001001311: Genome-wide study of resistance to severe malaria in eleven worldwide populations:PNG | Illumina Omni 2.5M | 815 |
EGAD00010001736 | EGAS00001001311: Genome-wide study of resistance to severe malaria in eleven worldwide populations:Nigeria | Illumina Omni 2.5M | 419 |
EGAD00010001737 | EGAS00001001311: Genome-wide study of resistance to severe malaria in eleven worldwide populations:Mali | Illumina Omni 2.5M | 900 |
EGAD00010001738 | EGAS00001001311: Genome-wide study of resistance to severe malaria in eleven worldwide populations:Gambia | Illumina Omni 2.5M | 5594 |
EGAD00010001739 | EGAS00001001311: Genome-wide study of resistance to severe malaria in eleven worldwide populations:BurkinaFaso | Illumina Omni 2.5M | 1446 |
EGAD00010001740 | EGAS00001001311: Genome-wide study of resistance to severe malaria in eleven worldwide populations:Cameroon | Illumina Omni 2.5M | 1471 |
EGAD00010001741 | EGAS00001001311: Genome-wide study of resistance to severe malaria in eleven worldwide populations:Malawi | Illumina Omni 2.5M | 3088 |
EGAD00010001742 | EGAS00001001311: Genome-wide study of resistance to severe malaria in eleven worldwide populations:Kenya | Illumina Omni 2.5M | 3865 |
EGAD00010001743 | EGAS00001001311: Genome-wide study of resistance to severe malaria in eleven worldwide populations:Tanzania | Illumina Omni 2.5M | 979 |
EGAD00010001748 | EGAS00001001311: Genome-wide study of resistance to severe malaria in eleven worldwide populations: phased genotypes | Illumina Omni 2.5M | 17960 |